NICE - Endorsed Clinical Guidelines 2018/2019

Topics:

It is important to note that the advice contained within the guidance does not override or replace the individual responsibility of health professionals to make appropriate decisions in the circumstances of their individual patients, in consultation with the patient and/or guardian or carer. This would, for example, include situations where individual patients have other conditions or complications that need to be taken into account in determining whether the NICE guidance is fully appropriate in their case. Clinical guidelines frequently make reference to specific legislation and guidance that do not apply in Northern Ireland. All clinical guidelines should be read taking these differences into consideration. The following NICE clinical guidelines have been endorsed during 2018/2019

Clinical Guidelines

Fully Endorsed 

March 2019

National Institute for Health and Clinical Excellence (NICE) NG118 - Renal and ureteric stones: assessment and management - HSC (SQSD) (NICE NG118) 07/19

National Institute for Health and Clinical Excellence (NICE) NG119 - Cerebral palsy in adults - HSC (SQSD) (NICE NG119) 08/19

January 2019

National Institute for Health and Clinical Excellence (NICE) NG115 - Chronic obstructive pulmonary disease in over 16s: diagnosis and management - HSC (SQSD) (NICE NG115) 01/19

  • This guidance updates and replaces NICE Clinical Guideline CG101, endorsed by DoH in May 2012

National Institute for Health and Clinical Excellence (NICE) NG116 - Post-traumatic stress disorder - HSC (SQSD) (NICE NG116) 02/19

November 2018

National Institute for Health and Clinical Excellence (NICE) NG106 - Chronic heart failure in adults: diagnosis and management - HSC (SQSD) NICE NG106 32/18

  • This guidance updates and replaces NICE Clinical Guideline CG108, endorsed by DoH in May 2011.

National Institute for Health and Clinical Excellence (NICE) NG107 - Renal replacement therapy and conservative management - HSC (SQSD) NICE NG107 34/18

  • This guidance updates and replaces NICE Clinical Guideline CG125, endorsed by DoH in May 2012

October 2018

National Institute for Health and Clinical Excellence (NICE) NG104 - Pancreatitis - HSC (SQSD) NICE NG104 30/18

September 2018

National Institute for Health and Clinical Excellence (NICE) NG100 - Rheumatoid arthritis in adults: management - HSC (SQSD) NICE NG100 26/18

  • This guidance updates and replaces NICE Clinical Guideline CG79, endorsed by DoH in May 2012 and addendum February 2016.

National Institute for Health and Clinical Excellence (NICE) NG99 - Brain tumours (primary) and brain metastases in adults - HSC (SQSD) (NICE NG99 25/18

National Institute for Health and Clinical Excellence (NICE) NG101 - Early and locally advanced breast cancer: diagnosis and management (updates and replaces CG80 and TAs 107, 108, 109 and 112) - HSC (SQSD) (NICE NG101) 27/18

  • This guidance updates and replaces NICE Clinical Guideline CG80, endorsed by DoH in July 2010, NICE Technology Appraisals TA107, TA108, TA109 endorsed by DoH in January 2007 and TA112 endorsed by DoH in November 2007.

August 2018

National Institute for Health and Clinical Excellence (NICE) NG98 - Hearing Loss in Adults: assessment and management - HSC (SQSD) (NICE NG98) 22/18

National Institute for Health and Clinical Excellence (NICE) NG97 - Dementia: Assessment, management and support for people living with dementia and their carers (updates & replaces CG42 & partially updates TA217) - HSC (SQSD) (NICE NG97) 21/18

  • This guidance updates and replaces NICE Clinical Guideline CG42 and partially updates NICE Technology Appraisal TA217, endorsed by DoH in September 2011.

June 2018

National Institute for Health and Clinical Excellence (NICE) NG95 - Lyme Disease - HSC (SQSD) (NICE NG95) 14/18

May 2018

National Institute for Health and Clinical Excellence (NICE) NG87 - Attention deficit hyperactivity disorder: diagnosis and management (updates & replaces CG72 & TA98) - HSC (SQSD) (NICE NG87) 11/18

  • This guidance updates and replaces NICE Clinical Guideline CG72 endorsed by DoH in March 2009 / addendum issued April 2016 and NICE Technology Appraisal TA98 endorsed by DoH in May 2016.

​National Institute for Health and Clinical Excellence (NICE) NG88 - Heavy menstrual bleeding: assessment and management (updates & replaces CG44) - HSC (SQSD) (NICE NG88) 12/18

  • This guidance updates and replaces NICE Clinical Guideline CG44 endorsed by DoH in June 2007. 

​National Institute for Health and Clinical Excellence (NICE) NG89 - Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (updates & replaces CG92) - HSC (SQSD) (NICE NG89) 13/18

  • This guidance updates and replaces NICE Clinical Guideline CG92 endorsed by DoH in March 2011.

 

April 2018

National Institute for Health and Clinical Excellence (NICE) NG85 - Pancreatic cancer in adults: diagnosis and management - HSC (SQSD) (NICE NG85) 08/18

 

Related articles

Back to top